Missing/wrong data?
Log in to edit
A phase 1, single-dose study of fresolimumab, an anti-TGF-β antibody, in treatment-resistant primary focal segmental glomerulosclerosis
scientific article published on 2 March 2011
Author/s
author: Harm Peters, Howard Trachtman, Giuseppe Remuzzi, Debbie S Gipson
Work details
Publication date
March 2, 2011
-
-
Language
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.